Search Results - "Hennig, Renald"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Safety of MF59™ adjuvant by Schultze, Viola, D’Agosto, Vicente, Wack, Andreas, Novicki, Deborah, Zorn, Juergen, Hennig, Renald

    Published in Vaccine (19-06-2008)
    “…Abstract The need to enhance the immunogenicity of purified subunit antigens has prompted the development of new adjuvants. The adjuvant emulsion MF59™ has…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine by Zent, Olaf, Hennig, Renald

    Published in Vaccine (16-12-2004)
    “…Scattered cases of immediate allergic reactions occurred in the nineties after widespread use of the original (polygeline-based) pediatric tick-borne…”
    Get full text
    Journal Article
  5. 5

    A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data by Gidudu, Jane, Kohl, Katrin S, Halperin, Scott, Hammer, Sandra Jo, Heath, Paul T, Hennig, Renald, Hoet, Bernard, Rothstein, Edward, Schuind, Anne, Varricchio, Frederick, Walop, Wikke

    Published in Vaccine (09-12-2008)
    “…Abstract The need for developing a case definition and guidelines for a local reaction at or near the injection site, methods for the development of the case…”
    Get full text
    Journal Article
  6. 6

    Swelling at or near injection site: Case definition and guidelines for collection, analysis and presentation of immunization safety data by Kohl, Katrin S, Walop, Wikke, Gidudu, Jane, Ball, Leslie, Halperin, Scott, Hammer, Sandra Jo, Heath, Paul, Varricchio, Frederick, Rothstein, Edward, Schuind, Anne, Hennig, Renald

    Published in Vaccine (01-08-2007)
    “…[...]the Working Group decided to define all local swelling reactions as "swelling at or near injection site". [...]one has to be careful in selecting the most…”
    Get full text
    Journal Article
  7. 7

    Induration at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data by Kohl, Katrin S, Walop, Wikke, Gidudu, Jane, Ball, Leslie, Halperin, Scott, Hammer, Sandra Jo, Heath, Paul, Hennig, Renald, Rothstein, Edward, Schuind, Anne, Varricchio, Frederick

    Published in Vaccine (01-08-2007)
    “…The appropriate Brighton Collaboration documents defining these conditions need to be consulted and the local reaction(s), which best fits the description…”
    Get full text
    Journal Article
  8. 8

    Biologics safety preclinical, clinical and regulatory by Hennig, Renald

    Published in Expert opinion on drug safety (01-11-2003)
    “…Biologicals offer particular challenges for all concerned, whether they be scientific researchers, profit-oriented companies (including not yet…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Electronic Reporting for Clinical Drug Safety and Pharmacovigilance. 29 - 30 October 2002, Amsterdam, The Netherlands by Hennig, Renald

    Published in Expert opinion on drug safety (01-03-2003)
    “…The 31 January 2003 deadline for electronic reporting to the European Agency for the Evaluation of Medicinal Products has helped to focus industry and…”
    Get more information
    Journal Article
  11. 11

    Cellulitis at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data by Halperin, Scott, Kohl, Katrin S, Gidudu, Jane, Ball, Leslie, Hammer, Sandra Jo, Heath, Paul, Hennig, Renald, Labadie, Jerry, Rothstein, Edward, Schuind, Anne, Varricchio, Frederick, Walop, Wikke

    Published in Vaccine (01-08-2007)
    “…Because cellulitis after immunization can occur due to unsafe injection techniques or vaccine vial handling or storage, and because it can clinically be…”
    Get full text
    Journal Article
  12. 12

    Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data by Kohl, Katrin S, Ball, Leslie, Gidudu, Jane, Hammer, Sandra Jo, Halperin, Scott, Heath, Paul, Hennig, Renald, Labadie, Jerry, Rothstein, Edward, Schuind, Anne, Varricchio, Frederick, Walop, Wikke

    Published in Vaccine (01-08-2007)
    “…[...]the Working Group recognized that the distinction between abscesses of infectious etiology and sterile abscesses could not always be made on the basis of…”
    Get full text
    Journal Article
  13. 13

    Immediate allergic reactions after vaccinations: a post-marketing surveillance review by ZENT, Olaf, ARRAS-REITER, Cornelia, BROEKER, Michael, HENNIG, Renald

    Published in European journal of pediatrics (01-01-2002)
    “…Immediate systemic allergic reactions after vaccination with commonly used vaccines are very rare. Consequently, the risk of these reactions cannot be verified…”
    Get full text
    Journal Article
  14. 14

    Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers by ZENT, Olaf, HENNIG, Renald, BANZHOFF, Angelika, BRÖKER, Michael

    Published in Journal of travel medicine (01-03-2005)
    “…Vaccination against tick-borne encephalitis (TBE) has been successfully employed for many years in TBE-endemic countries. Post-marketing experience gained from…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19